Cargando…

Open Innovation in Medical and Pharmaceutical Research: A Literature Landscape Analysis

Open innovation in medical and pharmaceutical research has grown steadily over the last decade. However, the performance of the published literature in terms of the scientific impact and gaining social media attention remains largely unexplored. The scientific literature of open innovation was exami...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeung, Andy Wai Kan, Atanasov, Atanas G., Sheridan, Helen, Klager, Elisabeth, Eibensteiner, Fabian, Völkl-Kernsock, Sabine, Kletecka-Pulker, Maria, Willschke, Harald, Schaden, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840485/
https://www.ncbi.nlm.nih.gov/pubmed/33519448
http://dx.doi.org/10.3389/fphar.2020.587526
_version_ 1783643583729893376
author Yeung, Andy Wai Kan
Atanasov, Atanas G.
Sheridan, Helen
Klager, Elisabeth
Eibensteiner, Fabian
Völkl-Kernsock, Sabine
Kletecka-Pulker, Maria
Willschke, Harald
Schaden, Eva
author_facet Yeung, Andy Wai Kan
Atanasov, Atanas G.
Sheridan, Helen
Klager, Elisabeth
Eibensteiner, Fabian
Völkl-Kernsock, Sabine
Kletecka-Pulker, Maria
Willschke, Harald
Schaden, Eva
author_sort Yeung, Andy Wai Kan
collection PubMed
description Open innovation in medical and pharmaceutical research has grown steadily over the last decade. However, the performance of the published literature in terms of the scientific impact and gaining social media attention remains largely unexplored. The scientific literature of open innovation was examined by means of bibliometric analyses to identify the most prolific authors, organizations, countries, journals, research areas, and recurring terms. By accessing the Web of Science Core Collection and Altmetric electronic databases, citation-related and Altmetric data were evaluated. Public-private partnerships and a selection of newly introduced potential novel drugs in the analyzed publications were identified. North America and Europe were the major literature contributors. Research outputs were mainly published in journals focused on business and economics, pharmacology and pharmacy, and engineering. Many pharmaceutical and biotechnological companies contributed to the analyzed publications, with higher mean citation counts and social media attention (Altmetric score) than nonindustry articles. Public-private partnerships fostered financial support, sharing of expertise and intellectual property, and research collaborations. In summary, open innovation might serve as a powerful strategy to both benefit the involved industry entities and accelerate the development of solutions and products for the betterment of human health.
format Online
Article
Text
id pubmed-7840485
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-78404852021-01-29 Open Innovation in Medical and Pharmaceutical Research: A Literature Landscape Analysis Yeung, Andy Wai Kan Atanasov, Atanas G. Sheridan, Helen Klager, Elisabeth Eibensteiner, Fabian Völkl-Kernsock, Sabine Kletecka-Pulker, Maria Willschke, Harald Schaden, Eva Front Pharmacol Pharmacology Open innovation in medical and pharmaceutical research has grown steadily over the last decade. However, the performance of the published literature in terms of the scientific impact and gaining social media attention remains largely unexplored. The scientific literature of open innovation was examined by means of bibliometric analyses to identify the most prolific authors, organizations, countries, journals, research areas, and recurring terms. By accessing the Web of Science Core Collection and Altmetric electronic databases, citation-related and Altmetric data were evaluated. Public-private partnerships and a selection of newly introduced potential novel drugs in the analyzed publications were identified. North America and Europe were the major literature contributors. Research outputs were mainly published in journals focused on business and economics, pharmacology and pharmacy, and engineering. Many pharmaceutical and biotechnological companies contributed to the analyzed publications, with higher mean citation counts and social media attention (Altmetric score) than nonindustry articles. Public-private partnerships fostered financial support, sharing of expertise and intellectual property, and research collaborations. In summary, open innovation might serve as a powerful strategy to both benefit the involved industry entities and accelerate the development of solutions and products for the betterment of human health. Frontiers Media S.A. 2021-01-14 /pmc/articles/PMC7840485/ /pubmed/33519448 http://dx.doi.org/10.3389/fphar.2020.587526 Text en Copyright © 2021 Yeung, Atanasov, Sheridan, Klager, Eibensteiner, Völkl-Kernsock, Kletecka-Pulker, Willschke and Schaden. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Yeung, Andy Wai Kan
Atanasov, Atanas G.
Sheridan, Helen
Klager, Elisabeth
Eibensteiner, Fabian
Völkl-Kernsock, Sabine
Kletecka-Pulker, Maria
Willschke, Harald
Schaden, Eva
Open Innovation in Medical and Pharmaceutical Research: A Literature Landscape Analysis
title Open Innovation in Medical and Pharmaceutical Research: A Literature Landscape Analysis
title_full Open Innovation in Medical and Pharmaceutical Research: A Literature Landscape Analysis
title_fullStr Open Innovation in Medical and Pharmaceutical Research: A Literature Landscape Analysis
title_full_unstemmed Open Innovation in Medical and Pharmaceutical Research: A Literature Landscape Analysis
title_short Open Innovation in Medical and Pharmaceutical Research: A Literature Landscape Analysis
title_sort open innovation in medical and pharmaceutical research: a literature landscape analysis
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840485/
https://www.ncbi.nlm.nih.gov/pubmed/33519448
http://dx.doi.org/10.3389/fphar.2020.587526
work_keys_str_mv AT yeungandywaikan openinnovationinmedicalandpharmaceuticalresearchaliteraturelandscapeanalysis
AT atanasovatanasg openinnovationinmedicalandpharmaceuticalresearchaliteraturelandscapeanalysis
AT sheridanhelen openinnovationinmedicalandpharmaceuticalresearchaliteraturelandscapeanalysis
AT klagerelisabeth openinnovationinmedicalandpharmaceuticalresearchaliteraturelandscapeanalysis
AT eibensteinerfabian openinnovationinmedicalandpharmaceuticalresearchaliteraturelandscapeanalysis
AT volklkernsocksabine openinnovationinmedicalandpharmaceuticalresearchaliteraturelandscapeanalysis
AT kleteckapulkermaria openinnovationinmedicalandpharmaceuticalresearchaliteraturelandscapeanalysis
AT willschkeharald openinnovationinmedicalandpharmaceuticalresearchaliteraturelandscapeanalysis
AT schadeneva openinnovationinmedicalandpharmaceuticalresearchaliteraturelandscapeanalysis